| # | Drug | Count |
|---|---|---|
| 0 | FULVESTRANT | 33 |
| 1 | GOSERELIN | 23 |
| 2 | PALBOCICLIB | 22 |
| 3 | DENOSUMAB | 18 |
| 4 | LETROZOLE | 18 |
| 5 | RIBOCICLIB | 18 |
| 6 | CAPECITABINE | 17 |
| 7 | ANASTROZOLE | 16 |
| 8 | ANASTROZOLE TABLETS | 16 |
| 9 | CARBOPLATIN | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GOSERELIN | 23 | 0.0017 |
| 1 | FOSNETUPITANT AND PALONOSETRON | 2 | 0.0017 |
| 2 | NETUPITANT AND PALONOSETRON | 2 | 0.0017 |
| 3 | LANREOTIDE ACETATE | 11 | 0.0014 |
| 4 | TRIPTORELIN PAMOATE | 3 | 0.0012 |
| 5 | FULVESTRANT | 33 | 0.0010 |
| 6 | BRIGATINIB | 3 | 0.0008 |
| 7 | ANASTROZOLE TABLETS | 16 | 0.0007 |
| 8 | LOPERAMIDE HCL | 9 | 0.0007 |
| 9 | SIPULEUCEL-T | 4 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 48 |
| 1 | Aromatase Inhibitor [EPC] | 35 |
| 2 | Estrogen Receptor Antagonist [EPC] | 34 |
| 3 | Corticosteroid [EPC] | 19 |
| 4 | Microtubule Inhibitor [EPC] | 19 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 18 |
| 6 | Platinum-based Drug [EPC] | 18 |
| 7 | RANK Ligand Inhibitor [EPC] | 18 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 17 |
| 9 | Alkylating Drug [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Estrogen Receptor Antagonist [EPC] | 34 | 0.0008 |
| 1 | Autologous Cellular Immunotherapy [EPC] | 4 | 0.0007 |
| 2 | Aromatase Inhibitor [EPC] | 35 | 0.0003 |
| 3 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 2 | 0.0002 |
| 4 | Non-Standardized Insect Allergenic Extract [EPC] | 1 | 0.0002 |
| 5 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 6 | Standardized Insect Venom Allergenic Extract [EPC] | 1 | 0.0001 |
| 7 | Cannabinoid [EPC] | 1 | 0.0001 |
| 8 | Vitamin K [EPC] | 1 | 0.0001 |
| 9 | Microtubule Inhibitor [EPC] | 19 | 0.0001 |